AbbVie, Sosei Build In 2020 Pact With New Neurological Disease-Focused Agreement
Sosei Group Corporation and AbbVie Inc (NYSE:ABBV) announced a new drug discovery collaboration and option-to-license agreement to discover, develop and commercialize small molecules…